Datadog vs Atlassian
DDOG and TEAM side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DDOG and TEAM compare
Datadog is the larger company, worth 1.7 times as much as Atlassian ($84.5B against $48.5B).
Datadog grew revenue faster over the last twelve months (31.5% versus 26.0% for Atlassian).
Datadog keeps more of each dollar of sales as profit, with a net margin of 4.5% compared with −0.82% at Atlassian.
Datadog scores higher on the StockData Score (11 against 9 for Atlassian), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DDOG | TEAM |
|---|---|---|
| Size and price | ||
| Market cap | $84.5B | $48.5B |
| Share price | $235.27 | $191.72 |
| Change, 1 year | 50.8% | 20.4% |
| Change, 5 years | 26.8% | −56.4% |
| Beta (5Y) | 1.67 | 1.88 |
| Employees | 8,100 | 13K |
| StockData Score | ||
| Total score | 11 (better) | 9 |
| Valuation score | 0 | 0 |
| Growth score | 3 | 4 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 5 (better) | 3 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 471× | – |
| P/S | 21.3× | 7.4× (better) |
| P/B | 19.3× (better) | 45.9× |
| EV/EBITDA | 1015× | 320× (better) |
| P/FCF | 71.5× | 36.8× (better) |
| FCF yield | 1.4% | 2.7% (better) |
| Fair value | $19.80 | $42.85 |
| Margin of safety | −1088% | −347% (better) |
| Growth | ||
| Revenue growth (TTM) | 31.5% (better) | 26.0% |
| Revenue growth, 5Y average | 41.5% (better) | 25.8% |
| Net income growth (TTM) | 42.5% | – |
| EPS growth (TTM) | 42.9% | – |
| Profitability | ||
| Gross margin | 79.5% | 84.8% (better) |
| Operating margin | 0.41% (better) | 0.16% |
| Net margin | 4.5% (better) | −0.82% |
| FCF margin | 29.8% (better) | 20.1% |
| Return on equity | 4.7% (better) | −4.5% |
| Return on invested capital | – | 5.1% |
| Financial health | ||
| Debt / equity | 0.00 | 0.93 (better) |
| Net debt / EBITDA | – | −1.66 |
| Interest coverage | 1.4× (better) | 0.2× |
| Current ratio | 3.20 (better) | 0.78 |
| Altman Z-score | 17.17 (better) | 5.30 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 3.7% |
| Shareholder yield | 0.00% | 3.7% (better) |
| Ownership | ||
| Held by institutions | 84.7% | 62.8% |
| Held by insiders | 7.7% | 19.4% |
| Insider net buying, 12 months | −$890M | −$160M (better) |
| Short interest, % of float | 2.9% | 4.3% |
Go deeper
- DDOG stock overview
- DDOG income statement
- DDOG valuation and score
- TEAM stock overview
- TEAM income statement
- TEAM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.